RNA5SP378: A Potential Drug Target and Biomarker (G100873634)

Target Name: RNA5SP378

NCBI ID: G100873634

RNA5SP378

Other Name(s): RNA, 5S ribosomal pseudogene 378 | RN5S378

RNA5SP378: A Potential Drug Target and Biomarker

RNA5SP378 is a RNA molecule that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that contains 59 amino acid residues and is located in the gene HSP70B. HSP70B is a heat-spreading protein that is expressed in a variety of tissues and cells, including the heart, lungs, kidneys, and liver. RNA5SP378 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

The Discovery of RNA5SP378

RNA5SP378 was first identified using transcriptomics techniques. RNA sequencing (RNA-seq) was used to generate a comprehensive transcriptome profile of RNA5SP378 in mouse tissue samples. The results of the RNA-seq analysis revealed that RNA5SP378 was expressed in a variety of tissues and cells, including the heart, lung, liver, and kidney. RNA5SP378 was also shown to be expressed in human samples, including the placenta, liver, and heart.

The Function of RNA5SP378

RNA5SP378 has been shown to play a role in the regulation of cellular processes that are important for human health and disease. One of the most significant functions of RNA5SP378 is its role in cell apoptosis. Apoptosis is a natural process that is important for the regulation of cell growth and lifespan. When cells are no longer needed or are damaged, they undergo apoptosis, which allows the body to remove damaged or unnecessary cells. RNA5SP378 has been shown to be involved in the regulation of apoptosis, including the execution of programmed cell death.

RNA5SP378 has also been shown to play a role in the regulation of cell proliferation. Prolonged periods of cell proliferation can lead to the development of cancer, and RNA5SP378 has been shown to be involved in the regulation of cell proliferation. The RNA-seq analysis revealed that RNA5SP378 was expressed in a variety of tissues and cells, including the breast cancer cell line.

RNA5SP378 has also been shown to play a role in the regulation of inflammation. Chronic inflammation can lead to a host of diseases, including heart disease and diabetes. RNA5SP378 has been shown to be involved in the regulation of inflammation, including the production of pro-inflammatory cytokines.

The Potential of RNA5SP378 as a Drug Target

The potential of RNA5SP378 as a drug target is due to its involvement in a variety of cellular processes that are important for human health and disease. RNA5SP378 has been shown to play a role in the regulation of cell apoptosis, cell proliferation, and inflammation. This suggests that RNA5SP378 may be a useful target for drugs that are designed to modulate these processes.

RNA5SP378 has been shown to be expressed in a variety of tissues and cells, including the heart, lung, liver, and kidney. This suggests that RNA5SP378 may be a potential drug target that can be targeted by small molecules or other therapeutic agents. The RNA-seq analysis also revealed that RNA5SP378 was expressed in human samples, including the placenta, liver, and heart. This suggests that RNA5SP378 may be a potential drug target that can be targeted by therapies that are effective in these tissues.

RNA5SP378 has been shown to play a role in the regulation of cell apoptosis, including the execution of programmed cell death. This suggests that RNA5SP378 may be a potential drug target

Protein Name: RNA, 5S Ribosomal Pseudogene 378

The "RNA5SP378 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP378 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets